Search

In honor of his extraordinary contributions to improving the diagnosis and treatment of childhood cancer, Richard O’Reilly, Chairman of the Department of Pediatrics and Director of the Bone Marrow Transplantation Program at MSK, will receive the first Society of Memorial Sloan Kettering Prize.

… Monday, May 2, 2016 In honor of his extraordinary contributions to improving the diagnosis and treatment of childhood cancer, Richard O’Reilly, Chairman of the Department of Pediatrics and Director of the Bone Marrow Transplantation Program at MSK, will receive the first Society of Memorial Sloan Kettering

Structural Biology Program Chair Nikola P. Pavletich and immunologist Alexander Y. Rudensky have received one of the highest honors given to scientists working in the United States.

… Wednesday, May 30, 2012 Summary Structural Biology Program Chair Nikola P. Pavletich and immunologist Alexander Y. Rudensky have received one of the highest honors given to scientists working in the United States. Two Memorial Sloan Kettering investigators have been named members of the National Academy

… Monday, May 5, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Jennifer Oakvik and Adrienne Bloom Recognized by the Oncology Nursing Society Awards Jennifer Oakvik, MSN, RN, CMSRN, nurse leader,  received the Emerging Leader Award from the Oncology

The watch and wait approach to treatment, also called active surveillance, is common for lymphomas that pose no immediate threat to a patient’s health. But the tactic can leave some patients initially feeling anxious.

… Friday, April 8, 2016 Summary The watch and wait approach to treatment, also called active surveillance, is common treatment for lymphomas that pose no immediate threat to a patient’s health. This hands-off method has been proven to work just as well as active treatment in select patients, and negates

Memorial Sloan Kettering (MSK) has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research. The award recognizes promising investigators aged 45 or younger at the time of nomination for their efforts in advancing cancer research.

… Thursday, November 9, 2017 Memorial Sloan Kettering (MSK) has named three investigators as recipients of this year’s Paul Marks Prize for Cancer Research . The award recognizes promising investigators aged 45 or younger at the time of nomination for their efforts in advancing cancer research. The winners

Learn what blood in the urine may mean, and why you should never ignore it.

… Wednesday, July 30, 2025 Blood in the urine can be a sign of infection, kidney stones, or cancer, especially bladder cancer .   Anyone with blood in their urine should have a doctor investigate the cause. Blood in the urine, also called hematuria, is a sure sign that something is wrong. But it can be

The MSK Immigrant Health & Cancer Disparities service improves people’s lives in communities that too often get overlooked and suffer disproportionately from cancer, including lack of access to care.

… Thursday, April 1, 2021 A New York City taxi garage at 4:00 a.m. may seem like the last place to look for medical advice. But that made it perfect for internist Francesca Gany and her team of ten. Before dawn on a January day in 2016, they set up a health fair amid the grinding noise and choking exhaust

Thyroid lobectomy alone is an effective and safe treatment option for carefully selected patients with papillary thyroid cancer, according to a retrospective study by Memorial Sloan Kettering Cancer Center.

… Thursday, January 29, 2026 Thyroid lobectomy alone is an effective and safe treatment option for carefully selected patients with papillary thyroid cancer, according to a retrospective study by Memorial Sloan Kettering Cancer Center (MSK). Thyroid lobectomy (TL) provided survival and recurrence outcomes

This research marks the first time researchers have found a connection between vitamin B6 and cancer.

… Monday, January 13, 2020 Summary Researchers made the discovery while searching for molecular vulnerabilities that could be targeted in AML cells while sparing normal cells. Tumors require many building blocks to support the cell division needed to grow and spread. For that reason, an important approach

The National Institutes of Health's National Cancer Institute has awarded The City College of New York and Memorial Sloan Kettering Cancer Center a $15.9 million grant to implement a unique partnership in cancer research, education, and outreach.

… Wednesday, February 25, 2009 The National Institutes of Health’s National Cancer Institute (NCI) has awarded The City College of New York (CCNY) and Memorial Sloan Kettering Cancer Center (MSKCC) a $15.9 million grant to implement a unique partnership in cancer research, education, and outreach. The